Senna Benefits

Senna (Senna alexandrina Mill., family Fabaceae — also catalogued as Cassia senna, Cassia angustifolia and Cassia acutifolia) is one of a very small number of plants on this site that is not a candidate remedy awaiting better evidence. It is a licensed medicine. In the United States it sits in the Food and Drug Administration’s over-the-counter monograph for laxative drug products; in the United Kingdom and across the European Union it holds full marketing authorisations and traditional-use registrations; it is on the World Health Organization’s list of essential medicines. You can buy it in a pharmacy under names such as Senokot and ex-lax, and hospices hand it out with every new opioid prescription.

So the interesting question about senna is not “does it work.” It does. Placebo-controlled trials have measured the effect, and it is not subtle. The interesting question is the one almost no marketing copy answers: what is it for, for how long, and what happens to people who ignore that. Senna’s harms are almost entirely harms of duration and context. A dose taken tonight for a blocked-up week of travel is an ordinary, sensible use of an ordinary, sensible drug. The same dose taken every night for two years, or brewed into a “14-day detox” tea and drunk for weight control, is how people end up in an emergency department with a potassium of 2.4.

These four articles cover both halves honestly: the real pharmacology and the real trial data, and then the real risks — electrolyte loss, the pigmented colon lining called melanosis coli, the long-running argument about whether chronic use produces a “cathartic colon,” and the slimming-tea market where most of the genuine harm actually occurs.

Table of Contents

1. Deep-Dive Articles
2. What Senna Is and What It Is Licensed For
3. The Standard Dose, in One Table
4. Not the Same Plant as Senna alata
5. Where the Evidence Is Strong — and Where It Is Not
6. The Two-Week Rule, and Why It Exists
7. Key Research Papers
8. External Resources
9. Connections

Deep-Dive Articles

Start with short-term use — that is the licensed indication and the one supported by controlled trials. Read the long-term risk article before you decide to keep taking it.

What Senna Is and What It Is Licensed For

Senna is a small, drought-tolerant shrub of the pea family that grows across the Nile valley, the Arabian peninsula, the Horn of Africa and India. Two commercial sources dominate: Alexandrian senna, historically shipped from Egypt and Sudan, and Tinnevelly senna, grown in southern India. Both are now treated as the single species Senna alexandrina. Two plant parts are used:

• Senna leaf (Sennae folium) — the dried leaflets. Higher in sennosides and, in traditional practice, considered the harsher of the two.
• Senna pod (Sennae fructus) — the flat, dried seed pods. Generally described as gentler and better tolerated, and the form usually preferred in European pharmacopoeial preparations.

The regulatory position is unusually clear for a botanical. Senna appears in the US FDA OTC monograph for stimulant laxatives, meaning products can be sold as drugs with approved labelling rather than as dietary supplements. In the European Union, the Committee on Herbal Medicinal Products has issued monographs for both leaf and pod covering short-term use in occasional constipation. The World Health Organization includes senna in its Model List of Essential Medicines. The German Commission E approved it decades ago. This is not a plant that needs anyone’s advocacy.

What every one of those authorisations says, in nearly identical words, is that senna is for occasional constipation and should not be used for more than about one to two weeks without medical advice. That restriction is part of the licence, not a disclaimer bolted on by a cautious lawyer.

The Standard Dose, in One Table

Modern senna products are standardised to sennosides, usually expressed as sennoside B. This matters more than any other label feature: crude leaf varies severalfold in potency between harvests, but a tablet labelled “8.6 mg sennosides” delivers 8.6 mg.

The single most common self-inflicted injury with senna is not overdose in milligrams — it is overdose in weeks.

Not the Same Plant as Senna alata

The genus Senna contains more than 300 species and two of them are widely used medicinally for completely different purposes. Confusing them is common in online writing and occasionally in product labelling.

They share the anthraquinone chemistry of the genus, which is why S. alata leaf also has a laxative effect if eaten in quantity — but its documented use is on the skin, not in the gut. Our separate page on Cassia alata (Ringworm Bush) covers that species. If a product says “senna” and shows a picture of a bright yellow candle-shaped flower spike, it is alata, not alexandrina.

Where the Evidence Is Strong — and Where It Is Not

The Two-Week Rule, and Why It Exists

Every regulator that has looked at senna landed on roughly the same duration limit. It is worth understanding what that limit is actually protecting against, because the popular explanation is only partly right.

1. Electrolyte loss is the real hazard. Stimulant laxatives make the colon secrete fluid. Do that repeatedly and you lose water, sodium and — most importantly — potassium. Low potassium causes muscle weakness, cramps and, in the wrong patient, dangerous heart rhythms. It is also directly dangerous alongside potassium-lowering drugs: digoxin becomes more toxic when potassium falls, and thiazide or loop diuretics add their own losses to senna’s.
2. Low potassium makes constipation worse. Potassium is needed for smooth-muscle contraction. Lose enough and the colon slows down — which feels exactly like the laxative “stopping working,” and invites a larger dose. That loop is the mechanism behind most escalating laxative use, and it is far better documented than nerve damage.
3. The colon does change colour. Months of anthraquinone use deposits brown-black pigment in the lining, a finding called melanosis coli. It is startling on a colonoscopy report and it is benign — it fades within months of stopping, and prospective work found no increase in colorectal cancer or adenomas in anthranoid users.
4. Whether the colon is permanently damaged is genuinely unsettled. The old “cathartic colon” picture came from radiology and autopsy studies in an era of much harsher laxatives. Some rodent work found neuronal changes; other work specifically testing sennosides found no myenteric neuron death. Reviews since the 1990s have argued the dependence story is largely unsupported; a 2024 critical review revisited the whole question and found the evidence for gut damage weak. The honest position is that nobody has run the trial that would settle it, so the two-week rule is precaution, not proof.
5. Persistent constipation is a symptom, not a diagnosis. If you still need a laxative after two weeks, the useful question is why — hypothyroidism, medication side effects, pelvic floor dysfunction, low fibre, diabetes, or something that needs looking at. Escalating the dose answers none of those.

Key Research Papers

Every identifier below was checked live against NCBI E-utilities before it was written: author, title, journal and year all had to match. Where a paper could not be confirmed that way, a PubMed topic search appears instead of a number that might point at the wrong study.

Efficacy in constipation

1. Morishita D, Tomita T, Mori S, et al. Senna versus magnesium oxide for the treatment of chronic constipation: a randomized, placebo-controlled trial. The American Journal of Gastroenterology. 2021;116(1):152–161. The most useful modern trial: senna beat placebo, and was compared head-to-head with magnesium oxide.
2. Ford AC, Suares NC. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut. 2011;60(2):209–218.
3. Ramkumar D, Rao SSC. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. The American Journal of Gastroenterology. 2005;100(4):936–971.
4. Passmore AP, Wilson-Davies K, Stoker C, Scott ME. Chronic constipation in long stay elderly patients: a comparison of lactulose and a senna-fibre combination. BMJ. 1993;307(6907):769–771.

Opioid-induced constipation and palliative care

1. Agra Y, Sacristán A, González M, Ferrari M, Portugués A, Calvo MJ. Efficacy of senna versus lactulose in terminal cancer patients treated with opioids. Journal of Pain and Symptom Management. 1998;15(1):1–7.
2. Candy B, Jones L, Larkin PJ, Vickerstaff V, Tookman A, Stone P. Laxatives for the management of constipation in people receiving palliative care. Cochrane Database of Systematic Reviews. 2015;(5):CD003448. Found the evidence base small and no laxative clearly superior — an honest negative for anyone claiming senna is proven best here.
3. Marciniak CM, Toledo S, Lee J, et al. Lubiprostone vs senna in postoperative orthopedic surgery patients with opioid-induced constipation: a double-blind, active-comparator trial. World Journal of Gastroenterology. 2014;20(43):16323–16333.

Mechanism and pharmacokinetics

1. de Witte P. Metabolism and pharmacokinetics of anthranoids. Pharmacology. 1993;47(Suppl 1):86–97.
2. Akao T, Che QM, Kobashi K, Yang L, Hattori M, Namba T. Isolation of a human intestinal anaerobe, Bifidobacterium sp. strain SEN, capable of hydrolyzing sennosides to sennidins. Applied and Environmental Microbiology. 1994;60(3):1041–1043.
3. Krumbiegel G, Schulz HU. Rhein and aloe-emodin kinetics from senna laxatives in man. Pharmacology. 1993;47(Suppl 1):120–124.

Long-term safety, melanosis coli and the cathartic-colon debate

1. Whorwell P, Lange R, Scarpignato C. Review article: do stimulant laxatives damage the gut? A critical analysis of current knowledge. Therapeutic Advances in Gastroenterology. 2024;17:17562848241249664.
2. Müller-Lissner SA, Kamm MA, Scarpignato C, Wald A. Myths and misconceptions about chronic constipation. The American Journal of Gastroenterology. 2005;100(1):232–242.
3. Nusko G, Schneider B, Schneider I, Wittekind C, Hahn EG. Anthranoid laxative use is not a risk factor for colorectal neoplasia: results of a prospective case control study. Gut. 2000;46(5):651–655.
4. van Gorkom BA, de Vries EG, Karrenbeld A, Kleibeuker JH. Review article: anthranoid laxatives and their potential carcinogenic effects. Alimentary Pharmacology & Therapeutics. 1999;13(4):443–452.
5. Walker NI, Bennett RE, Axelsen RA. Melanosis coli: a consequence of anthraquinone-induced apoptosis of colonic epithelial cells. The American Journal of Pathology. 1988;131(3):465–476.

Misuse, weight control and eating disorders

1. Bo-Linn GW, Santa Ana CA, Morawski SG, Fordtran JS. Purging and calorie absorption in bulimic patients and normal women. Annals of Internal Medicine. 1983;99(1):14–17. The metabolic-ward study that measured how few calories purging actually removes.
2. Roerig JL, Steffen KJ, Mitchell JE, Zunker C. Laxative abuse: epidemiology, diagnosis and management. Drugs. 2010;70(12):1487–1503.
3. Vanderperren B, Rizzo M, Angenot L, Haufroid V, Jadoul M, Hantson P. Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides. The Annals of Pharmacotherapy. 2005;39(7–8):1353–1357.

Live PubMed Searches

1. Senna alexandrina
2. Sennosides and constipation
3. Rhein anthrone
4. Melanosis coli
5. Cathartic colon
6. Laxative abuse and hypokalaemia
7. Opioid-induced constipation and senna
8. Anthranoid laxatives and colorectal neoplasia

External Resources

• PubMed — Senna alexandrina literature
• LiverTox — NIH database of drug and herbal liver injury
• PubChem — sennoside A compound record
• NCCIH — Herbs at a Glance
• European Medicines Agency — senna leaf herbal monograph
• World Flora Online — Senna alexandrina Mill. taxonomy

Connections

• All Herbs
• Senna — the main topic page
• Cassia alata (Ringworm Bush) — the other medicinal Senna, used on skin
• Marshmallow Root — a soothing, non-stimulant gut herb
• Slippery Elm — mucilage rather than stimulation
• Potassium — the electrolyte senna depletes
• Gastroenterology — digestive conditions
• Constipation — causes, red flags and first-line steps
• Natural Constipation Relief
• Prunes — the food with the best constipation evidence

Back to Table of Contents